JP2015521728A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015521728A5 JP2015521728A5 JP2015516504A JP2015516504A JP2015521728A5 JP 2015521728 A5 JP2015521728 A5 JP 2015521728A5 JP 2015516504 A JP2015516504 A JP 2015516504A JP 2015516504 A JP2015516504 A JP 2015516504A JP 2015521728 A5 JP2015521728 A5 JP 2015521728A5
- Authority
- JP
- Japan
- Prior art keywords
- expression level
- compound
- protein
- genotoxic
- ser1981
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261659024P | 2012-06-13 | 2012-06-13 | |
| US61/659,024 | 2012-06-13 | ||
| PCT/EP2013/001575 WO2013185884A1 (en) | 2012-06-13 | 2013-05-28 | Protein expression analyses for identifying genotoxic compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015521728A JP2015521728A (ja) | 2015-07-30 |
| JP2015521728A5 true JP2015521728A5 (https=) | 2016-07-21 |
| JP6301915B2 JP6301915B2 (ja) | 2018-03-28 |
Family
ID=48536789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015516504A Expired - Fee Related JP6301915B2 (ja) | 2012-06-13 | 2013-05-28 | 遺伝毒性化合物を同定するためのタンパク質発現分析 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20150140123A1 (https=) |
| EP (1) | EP2861985B1 (https=) |
| JP (1) | JP6301915B2 (https=) |
| CN (1) | CN104364649B (https=) |
| AU (1) | AU2013276950B2 (https=) |
| CA (1) | CA2876402A1 (https=) |
| ES (1) | ES2660131T3 (https=) |
| IL (1) | IL236195B (https=) |
| WO (1) | WO2013185884A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9470694B2 (en) | 2013-03-09 | 2016-10-18 | Litron Laboratories Ltd. | Simplified nuclei analysis platform and biomarker matrix that supports genotoxic mode of action determinations |
| WO2014152873A1 (en) * | 2013-03-14 | 2014-09-25 | Pioma Inc. | Microvesicle histone h2ax as a biomarker for genotoxic stress |
| CN104515760B (zh) * | 2014-12-17 | 2017-10-31 | 深圳市纳观生物有限公司 | 双色荧光定位超分辨率生物显微方法及系统 |
| WO2017145816A1 (ja) * | 2016-02-24 | 2017-08-31 | ソニー株式会社 | 光学測定器、フローサイトメータ、および放射線計数器 |
| CN107159327B (zh) | 2017-05-17 | 2019-04-19 | 京东方科技集团股份有限公司 | 一种生物检测芯片及其检测方法 |
| CN110333207A (zh) * | 2019-06-25 | 2019-10-15 | 中国人民解放军陆军军医大学第一附属医院 | CREB在Ang-2调节VEGFR2表达中分析方法 |
| WO2021102420A1 (en) * | 2019-11-22 | 2021-05-27 | The Regents Of The University Of California | Interferon signaling as a cancer biomarker |
| CN112680498A (zh) * | 2020-12-28 | 2021-04-20 | 华南理工大学 | 一种遗传毒性物质的高通量筛查方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0411198D0 (en) * | 2004-05-20 | 2004-06-23 | Gentronix Ltd | Genotoxic testing |
| WO2006056340A2 (en) * | 2004-11-24 | 2006-06-01 | F. Hoffmann-La Roche Ag | Method for determining genotoxicity |
| WO2009080219A1 (en) * | 2007-12-20 | 2009-07-02 | F. Hoffmann-La Roche Ag | Prediction of genotoxicity |
| GB0905410D0 (en) * | 2009-03-28 | 2009-05-13 | Gentronix Ltd | Genotoxicity testing |
| DE102010024898B4 (de) * | 2010-06-24 | 2012-10-25 | Merck Patent Gmbh | Genexpressionsanalysen zur Charakterisierung und Identifizierung genotoxischer Verbindungen |
-
2013
- 2013-05-28 AU AU2013276950A patent/AU2013276950B2/en not_active Ceased
- 2013-05-28 EP EP13725576.6A patent/EP2861985B1/en not_active Not-in-force
- 2013-05-28 ES ES13725576.6T patent/ES2660131T3/es active Active
- 2013-05-28 CN CN201380030301.2A patent/CN104364649B/zh not_active Expired - Fee Related
- 2013-05-28 US US14/405,626 patent/US20150140123A1/en not_active Abandoned
- 2013-05-28 JP JP2015516504A patent/JP6301915B2/ja not_active Expired - Fee Related
- 2013-05-28 WO PCT/EP2013/001575 patent/WO2013185884A1/en not_active Ceased
- 2013-05-28 CA CA2876402A patent/CA2876402A1/en not_active Abandoned
-
2014
- 2014-12-11 IL IL236195A patent/IL236195B/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015521728A5 (https=) | ||
| Kalu et al. | Genomic characterization of human papillomavirus-positive and-negative human squamous cell cancer cell lines | |
| El-Shinawi et al. | Human cytomegalovirus infection enhances NF-κB/p65 signaling in inflammatory breast cancer patients | |
| Kuo et al. | High-resolution chromatin immunoprecipitation (ChIP) sequencing reveals novel binding targets and prognostic role for SOX11 in mantle cell lymphoma | |
| Arter et al. | Virus–polymer hybrid nanowires tailored to detect prostate-specific membrane antigen | |
| Cai et al. | STAT3-dependent transactivation of miRNA genes following Toxoplasma gondii infection in macrophage | |
| JP2015505370A5 (https=) | ||
| Xie et al. | Upregulator of cell proliferation predicts poor prognosis in hepatocellular carcinoma and contributes to hepatocarcinogenesis by downregulating FOXO3a | |
| JP2016500110A5 (https=) | ||
| JP2012524278A5 (https=) | ||
| JP2014144959A5 (https=) | ||
| Liu et al. | Human papillomavirus as a favorable prognostic factor in a subset of head and neck squamous cell carcinomas: A meta‐analysis | |
| Malz et al. | Overexpression of far upstream element (FUSE) binding protein (FBP)‐interacting repressor (FIR) supports growth of hepatocellular carcinoma | |
| Gusho et al. | Human papillomaviruses target the DNA damage repair and innate immune response pathways to allow for persistent infection | |
| Zhang et al. | The clinical significance of endothelin receptor type B in hepatocellular carcinoma and its potential molecular mechanism | |
| Khan et al. | Mercury exposure induces cytoskeleton disruption and loss of renal function through epigenetic modulation of MMP9 expression | |
| Liao et al. | Clinical significance and gene expression study of human hepatic stellate cells in HBV related-hepatocellular carcinoma | |
| Zhu et al. | Hepatitis B virus X protein driven alpha fetoprotein expression to promote malignant behaviors of normal liver cells and hepatoma cells | |
| Xin et al. | miR-155 accelerates the growth of human liver cancer cells by activating CDK2 via targeting H3F3A | |
| JP2021510833A5 (https=) | ||
| Taylor et al. | Inhibition of TNF‐α‐induced activation of NF‐κB by hantavirus nucleocapsid proteins | |
| Schultz et al. | Tumor-promoting role of signal transducer and activator of transcription (Stat) 1 in late-stage melanoma growth | |
| Koh et al. | Epstein‐Barr virus positivity is associated with angiogenesis in, and poorer survival of, patients receiving standard treatment for classical Hodgkin's lymphoma | |
| Graf et al. | New insight into the phosphorylation-regulated intranuclear localization of human cytomegalovirus pUL69 mediated by cyclin-dependent kinases (CDKs) and viral CDK orthologue pUL97 | |
| Zhang et al. | Targeting kinesins for therapeutic exploitation of chromosomal instability in lung cancer |